trastuzumab vedotin (MRG002)

News alerts, weekly reports and conference planners

Company:

Lepu Med

Drug class:

Microtubule inhibitor, HER2-targeted antibody-drug conjugate

HER-2 positive	Gastric Cancer	HER-2 positive	Gastric Cancer	MRG002 Sensitive: C2 – Inclusion Criteria MRG002 Sensitive : C2	MRG002 Sensitive: C2 – Inclusion Criteria MRG002 Sensitive : C2
HER-2 positive	HER2 Positive Breast Cancer	HER-2 positive	HER2 Positive Breast Cancer	MRG002 Sensitive: C2 – Inclusion Criteria MRG002 Sensitive : C2	MRG002 Sensitive: C2 – Inclusion Criteria MRG002 Sensitive : C2
HER-2 underexpression	Breast Cancer	HER-2 underexpression	Breast Cancer	MRG002 Sensitive: C3 – Early Trials MRG002 Sensitive : C3	MRG002 Sensitive: C3 – Early Trials MRG002 Sensitive : C3

Associations
(3)